DNMT3A and mature T-cell and NK-cell non-Hodgkin lymphoma: Among them, mutations of DNA methylation genes including TET2 (38–49%), DNMT3A (5–36%), and IDH2-R172 (0–8%) have been identified in patients with PTCL-NOS [9–13].